Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

A spirited debate is playing out in Washington, D.C., over what the government should tell Americans about spirits.

New research suggests that cancer survivors experiencing pain are more likely to use cannabis and cigarettes but less likely to consume alcohol.

Alcohol made me feel bold, magnetic, and irresistible—until it didn’t. Here’s what I wish I knew back then about its hidden impact on confidence, attraction, and self-image.

It can be hard to drink less, for many people, socializing seems to revolve around food and alcohol. Our culture has ...

Excessive drinking not only impacts young adults' physical health the following day, but also their emotional wellness, new ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Each year in the USA, alcohol use contributes to nearly 100 000 new cancer cases and 20 000 deaths from cancer, according to ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...